Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Phase II/III Medical Study Compares Safety and Efficacy of 2 Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency

Nov 13th, 2009
by admin.

PHILADELPHIA, PA - (HSMN NewsFeed) - Eurand N.V. (NASDAQ:EURX ), a global specialty medical company, today announced data from a Phase II/III clinical study demonstrating that ZENPEP(TM) (pancrelipase) Delayed-Release Capsules significantly improves…
Biopharmaceuticals
Eurand, ZENPEP, pancrelipase, exocrine pancreatic insufficiency, pancreatitis

Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency

Posted in: Medical Sales Jobs.

← Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement
nContact Announces Initiation of Medical Trials for the Treatment of Atrial Fibrillation in Open-Chest Procedures →

0 Comments on “Phase II/III Medical Study Compares Safety and Efficacy of 2 Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency”

Leave a Comment